Related Experiment Video
Updated: Jul 19, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
Bone marrow fibrosis (pseudo-myelofibrosis) in human kala-azar
F D Rocha Filho1, F V Ferreira, F de O Mendes
1Department of Pathology and Legal Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brasil.
Abstract:
Thirty cases of human kala-azar were diagnosed by iliac crest biopsy and myeloculture. Histological analysis of 12 patients showed diffuse thickening of reticulin fibers. To the best of our knowledge, this is the third report describing secondary bone marrow fibrosis (myelofibrosis-like) associated with kala-azar. Patients with positive bone marrow fibrosis (pbmf = 12) were compared to patients without detectable bone marrow fibrosis (wbmf = 18). There were no significant differences in clinical and blood parameters following treatment. All patients showed regression of hepatosplenomegaly. Our findings suggest that associated bone marrow fibrosis is transient and did not interfere in the evolution of treated patients.
Insights
Kala-azar can cause bone marrow fibrosis, a condition where reticulin fibers thicken. This fibrosis appears transient and does not impact treatment outcomes for patients with visceral leishmaniasis.
Area of Science:
- Tropical Medicine
- Hematology
- Pathology
Background:
- Visceral leishmaniasis, also known as kala-azar, is a serious parasitic disease.
- Bone marrow fibrosis, a condition characterized by reticulin fiber thickening, has been rarely associated with kala-azar.
Purpose of the Study:
- To investigate the occurrence and impact of bone marrow fibrosis in patients diagnosed with human kala-azar.
- To compare clinical and hematological parameters between kala-azar patients with and without bone marrow fibrosis.
Main Methods:
- Diagnosis of 30 human kala-azar cases using iliac crest biopsy and myeloculture.
- Histological analysis of bone marrow biopsies to identify reticulin fiber thickening.
- Comparison of patients with (n=12) and without (n=18) detectable bone marrow fibrosis.
Main Results:
- Histological analysis revealed diffuse reticulin fiber thickening (bone marrow fibrosis) in 12 out of 30 kala-azar patients.
- No significant differences in clinical or blood parameters were observed post-treatment between patients with and without bone marrow fibrosis.
- All patients demonstrated regression of hepatosplenomegaly after treatment.
Conclusions:
- Secondary bone marrow fibrosis (myelofibrosis-like) is a potential, albeit transient, complication associated with kala-azar.
- The presence of bone marrow fibrosis did not adversely affect the treatment outcomes or clinical evolution of kala-azar patients.
More Related Videos
14:30Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
06:33Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Related Concept Videos
Rocky Mountain Spotted Fever
Leishmaniasis
Malaria